F.L. Putnam Investment Management’s JPMorgan Equity Premium Income ETF JEPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$736K Sell
13,032
-8,516
-40% -$481K 0.01% 410
2026
Q1
$1.22M Buy
21,548
+2,098
+11% +$122K 0.02% 302
2025
Q4
$1.11M Buy
19,450
+722
+4% +$41.2K 0.02% 316
2025
Q3
$1.07M Buy
18,728
+1,020
+6% +$57.9K 0.02% 326
2025
Q2
$1.01M Sell
17,708
-11,928
-40% -$661K 0.02% 320
2025
Q1
$1.69M Buy
29,636
+5,460
+23% +$318K 0.03% 258
2024
Q4
$1.39M Buy
24,176
+7,064
+41% +$419K 0.03% 278
2024
Q3
$1.02M Sell
17,112
-8,096
-32% -$466K 0.02% 326
2024
Q2
$1.43M Buy
+25,208
New +$1.43M 0.03% 282

Other funds holding JEPI

F.L. Putnam Investment Management's JEPI Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its JPMorgan Equity Premium Income ETF (JEPI) stake by 40% in Q2 2026, selling an estimated $481K and leaving 13,032 shares worth $736K. The position accounts for 0.01% of the portfolio, ranked #410.

F.L. Putnam Investment Management first reported a position in JEPI in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.69M in Q1 2025. 1,071 funds tracked by Wall St. Rank hold JEPI as of Q2 2026.

  • F.L. Putnam Investment Management held 13,032 shares of JPMorgan Equity Premium Income ETF worth $736K as of Q2 2026.
  • F.L. Putnam Investment Management sold 8,516 JPMorgan Equity Premium Income ETF shares in Q2 2026, an estimated $481K.
  • JPMorgan Equity Premium Income ETF made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #410 holding.
  • F.L. Putnam Investment Management first reported a position in JPMorgan Equity Premium Income ETF in Q2 2024 and has held it in 9 quarters since.
  • F.L. Putnam Investment Management's JPMorgan Equity Premium Income ETF position peaked at $1.69M in Q1 2025.
  • 1,071 funds tracked by Wall St. Rank held JPMorgan Equity Premium Income ETF as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.